Valérie Boudreau

Valérie Boudreau

Auto-generated profile, based on publicly available information

Valérie Boudreau

Montreal Clinical Research Institute, Montreal, Quebec, Canada

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in Journal of Cystic Fibrosis
Verified
Journal Article
Closed access
JCJohann Colomba
Johann Colomba
VBValérie Boudreau
Valérie Boudreau
CLCatherine Lehoux-Dubois
Catherine Lehoux-Dubois
KDKatherine Desjardins
Katherine Desjardins
ACAdèle Coriati
Adèle Coriati
RRRémi Rabasa-Lhoret
Rémi Rabasa-Lhoret

1 March 2016 in Journal of Cystic Fibrosis
Verified
Journal Article
Closed access
VBValérie Boudreau
Valérie Boudreau
ACAdèle Coriati
Adèle Coriati
KDKatherine Desjardins
Katherine Desjardins
RRRémi Rabasa-Lhoret
Rémi Rabasa-Lhoret

1 November 2016 in Journal of Cystic Fibrosis
Verified
Journal Article
Closed access
VBValérie Boudreau
Valérie Boudreau
ACAdèle Coriati
Adèle Coriati
IHImane Hammana
Imane Hammana
SZSophie Ziai
Sophie Ziai
KDKatherine Desjardins
Katherine Desjardins
RRRémi Rabasa-Lhoret
Rémi Rabasa-Lhoret

28 August 2024 in Diabetes/Metabolism Research and Reviews
Verified
Journal Article
Open access
MLMarie‐Laure Lalanne‐Mistrih
Marie‐Laure Lalanne‐Mistrih
ABAnne Bonhoure
Anne Bonhoure
VMVirginie Messier
Virginie Messier
VBValérie Boudreau
Valérie Boudreau
MLMaha Lebbar
Maha Lebbar
RRRémi Rabasa‐Lhoret
Rémi Rabasa‐Lhoret
Aims: The prevalence and associations of overweight and obesity in Canadian adult people living with type 1 diabetes (PWT1D) are poorly documented. In a cohort of PWT1D patients, this study assesses (i) overweight and obesity frequencies and associated PWT1D clinicodemographic characteristics, (ii) diabetes characteristics, and (iii) the use of noninsulin adjunctive agents.Materials and Methods: Cross‐sectional analysis of self‐reported data from the BETTER registry: 1091 adult PWT1D (aged 44.4 ± 15.0 years; 32% HbA1c<7% [53 mmol/mol]) classified by BMI classes: underweight combined with normal weight, overweight, or obesity. Bivariate analyses were used to identify associations between BMI classes, diabetes characteristics, complications, and treatments.Results: Overweight and obesity affected 34.6% and 19.8% of participants. Compared to underweight + normal weight, PWT1D with overweight/obesity was associated with male sex, higher age, lower education level, longer diabetes duration, and higher total insulin doses and use of cardiorenal therapies (all p < 0.001). Compared to other PWT1D, those living with obesity reported higher HbA1c (p < 0.05), less frequent hypoglycemia (p < 0.05), more cardiovascular diseases (p < 0.003), retinopathy, neuropathy, depression treatment as well as noninsulin adjunctive agent use (all p < 0.001). Logistic regression showed that living with overweight/obesity was associated with male sex, being treated for cardiorenal therapies, depression, diabetes duration, and total daily insulin doses.Conclusions: Overweight or obesity affects over half of adult PWT1D in the Canadian BETTER registry and is associated with higher HbA1c levels, higher total daily insulin doses, more chronic diabetes complications and noninsulin adjunctive agent use, a worse cardiometabolic profile, and lower hypoglycemia frequency.

11 March 2021 in Diabetologia
Verified
Journal Article
Closed access
PDF file
ABAnne Bonhoure
Anne Bonhoure
KPKathryn J. Potter
Kathryn J. Potter
JCJohann Colomba
Johann Colomba
VBValérie Boudreau
Valérie Boudreau
CBCindy Bergeron
Cindy Bergeron
RRRémi Rabasa-Lhoret
Rémi Rabasa-Lhoret

5 October 2022 in Paediatric Respiratory Reviews
Verified
Journal Article
Closed access
BPBernadette Prentice
Bernadette Prentice
KPKathryn J. Potter
Kathryn J. Potter
ACAdèle Coriati
Adèle Coriati
VBValérie Boudreau
Valérie Boudreau
LRLeah Rusnell
Leah Rusnell
RRRémi Rabasa-Lhoret
Rémi Rabasa-Lhoret